Quadcap Wealth Management LLC Grows Position in CME Group Inc. (NASDAQ:CME)

Quadcap Wealth Management LLC raised its holdings in shares of CME Group Inc. (NASDAQ:CME) by 50.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,127 shares of the financial services provider’s stock after purchasing an additional 709 shares during the quarter. Quadcap Wealth Management LLC’s holdings in CME Group were worth $494,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. SJS Investment Consulting Inc. lifted its holdings in CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 97 shares during the last quarter. New Age Alpha Advisors LLC lifted its holdings in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 43 shares during the last quarter. Financial Life Planners purchased a new stake in CME Group during the fourth quarter valued at about $32,000. Knuff & Co LLC purchased a new stake in CME Group during the fourth quarter valued at about $33,000. Finally, Banque Transatlantique SA purchased a new stake in CME Group during the fourth quarter valued at about $35,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Trading Up 2.9%

Shares of CME opened at $274.00 on Friday. The firm’s 50 day simple moving average is $265.54 and its 200 day simple moving average is $246.70. The company has a market capitalization of $98.74 billion, a P/E ratio of 28.34, a P/E/G ratio of 6.76 and a beta of 0.45. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $286.48.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating analysts’ consensus estimates of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The business had revenue of $1.64 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same period last year, the business earned $2.50 earnings per share. The business’s quarterly revenue was up 10.4% on a year-over-year basis. Sell-side analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date of this dividend is Monday, June 9th. CME Group’s payout ratio is currently 50.30%.

Insider Buying and Selling at CME Group

In other news, insider Derek Sammann sold 4,650 shares of the firm’s stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $280.61, for a total value of $1,304,836.50. Following the transaction, the insider now owns 8,336 shares in the company, valued at approximately $2,339,164.96. This trade represents a 35.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 3,984 shares of the firm’s stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the completion of the transaction, the insider now owns 27,046 shares in the company, valued at $6,774,211.62. This represents a 12.84% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 23,134 shares of company stock worth $6,087,434 over the last ninety days. Insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

CME has been the topic of several recent research reports. Barclays upped their price objective on shares of CME Group from $279.00 to $283.00 and gave the company an “equal weight” rating in a report on Wednesday, April 23rd. Oppenheimer increased their price target on shares of CME Group from $269.00 to $279.00 and gave the stock an “outperform” rating in a report on Friday, April 11th. Morgan Stanley increased their price target on shares of CME Group from $301.00 to $304.00 and gave the stock an “overweight” rating in a report on Thursday, April 24th. UBS Group increased their price target on shares of CME Group from $290.00 to $305.00 and gave the stock a “buy” rating in a report on Friday, April 25th. Finally, Raymond James raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target on the stock in a report on Monday, March 10th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $256.80.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.